跳至主要内容
临床试验/RPCEC00000236
RPCEC00000236已完成2 期

Systemic ozone therapy by means rectal insuflaction applied of the patiens with inmunoglobulin A deficency. (OTIGAD-2) - OTIGAD-2

Roberto Rodriguez Fernandez General Hospital0 个研究点开始时间: 2017年2月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
4 years 至 50 years(—)
性别
All

入选标准

  • 1- IgA deficiency complete or partial, selective IgA deficiency or with deficient specific antibody response, IgAD isolated or associated to allergic , autoimmune and neoplasic illness.
  • 2- Informed Consent of the parents for the participation of childrens in the study or Signed informed consent of the adults .

排除标准

  • 1- Having received blood transfusions three previous months or during the study
  • 2- Having recived immunomodulator treatment 6 previous months to study.
  • 3- Any specific conditions that advise against any one of the treatments.

研究者

发起方
Roberto Rodriguez Fernandez General Hospital

相似试验